Hematologic Malignancies

Immunotherapy

Questions discussed in this category

How do you approach evaluation and management of arthralgia in a patient after CAR-T cell therapy?

1 Answer available

Is there a role for IL2-receptor antagonists and TNF-alpha inhibitors in cytokine release syndrome as a complication of CAR-T or immunotherapy?

1 Answer available

How early have you been able to detect a response with CAR-T in patients with relapsed DLBCL?

3 Answers available

Papers discussed in this category

The New England journal of medicine, 2017-12-28

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.

Exp Hematol Oncol, 2021 Feb 19

Etanercept as a new therapeutic option for cytokine release syndrome following chimeric antigen receptor T cell therapy.

Related Topics in Hematologic Malignancies